Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $68,528.77 +1.33%
Ethereum $1,988.39 +1.36%
BNB $626.90 +0.15%
Optimism $0.13 -0.02%
Arbitrum $0.10 +2.79%
Solana $86.23 +1.74%
Polygon $0.22 +2.77%
Cosmos $2.33 -0.72%
Avalanche $9.26 +1.32%

Bitcoin $68,528.77 +1.33%
Ethereum $1,988.39 +1.36%
BNB $626.90 +0.15%
Optimism $0.13 -0.02%
Arbitrum $0.10 +2.79%
Solana $86.23 +1.74%
Polygon $0.22 +2.77%
Cosmos $2.33 -0.72%
Avalanche $9.26 +1.32%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B